Micro Direct’s CO Check Pro breath carbon monoxide monitor has gained FDA 510k approval in the United States.
According to the US Department of Health and Human Services, cigarette smoking is the leading cause of preventable disease and death in the US, accounting for more than 480,000 deaths per year, including 140,000 from secondhand smoke.
“As a country, we have a strong focus on smoking cessation encouraging current smokers to quit and highlighting the associated health benefits. Carbon monoxide breath testing is a great and invaluable tool in assisting smokers to quit,” the company said in a press release.
The CO Check Pro with its clear display of a smokers exhaled carbon monoxide levels in parts per million (ppm) and percent carboxyhemoglobin (%COHb) levels along with visual colored lights on the levels of breath CO recorded, act as a great motivational tool in smoking cessation.
The CO Check Pro is easy to use and ensures the test can be performed quickly and efficiently assisting busy health care professionals in their role as smoking cessation advisers to reduce the burden of preventable deaths and disease associated with smoking.